Maxillary Sinusitis: Clinical Trials

4 trials for Maxillary Sinusitis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed. 4 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 34Completed 4

Follow Maxillary Sinusitis: new trials by email Literature Review of Maxillary Sinusitis trials Research Report on Maxillary Sinusitis

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study Evaluating the Safety and Efficacy of Treating Sinus Infection With Levofloxacin 750 mg for 5 Days.
levofloxacin - Maxillary Sinusitis
Phase 3CompletedJohnson & Johnson Pharmaceutical Research & Development, L.L.C.182003-11-012011-06-10
A Multicenter, Randomized, Double-Blind, Double-Dummy Trial of Azithromycin SR Compared With Levofloxacin for the Treatment of Sinus Infections in Adults
azithromycin SR (Zithromax; compound: CP-62,993), placebo, levofloxacin - Maxillary Sinusitis
Phase 3CompletedPfizer5412003-01-012011-05-11
AMS VS MOXI Ketek vs Avelox in AMS
Telithromycin - Maxillary Sinusitis
Phase 3CompletedSanofi3512002-12-012012-02-17
A Study of the Safety and Effectiveness of Levofloxacin Compared With Amoxicillin/Clavulanate Potassium in the Treatment of Adults With Rapid Onset of Severe Inflammation/Infection of the Sinuses
levofloxacin - Sinusitis, Maxillary Sinusitis
Phase 3CompletedJohnson & Johnson Pharmaceutical Research & Development, L.L.C.6141993-08-012011-06-10

Narrower conditions

Infections (1)  ·  Nose Diseases (1)  ·  Paranasal Sinus Diseases (1)  ·  Respiratory Tract Diseases (1)  ·  Respiratory Tract Infections (1)  ·  Sinusitis (1)

Broader conditions

Otorhinolaryngologic Diseases (4)  ·  Infections (3)  ·  Nose Diseases (3)  ·  Paranasal Sinus Diseases (3)  ·  Respiratory Tract Diseases (3)  ·  Respiratory Tract Infections (3)  ·  Sinusitis (3)

Interventions

Levofloxacin (3)  ·  Azithromycin (1)  ·  telithromycin (1)

Sponsors

Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (2)  ·  Pfizer (1)  ·  Sanofi (1)

Countries

United States (2)  ·  Argentina (1)  ·  Chile (1)  ·  Costa Rica (1)  ·  Czechia (1)  ·  Estonia (1)  ·  Germany (1)  ·  India (1)  ·  Lithuania (1)  ·  Mexico (1)  ·  Poland (1)  ·  Russia (1)  ·  Slovakia (1)

Results publications

PMID 17178300